Aug 31
AAWH · Ascend Wellness Holdings, Inc. · Documents
$0.40
+0.00 (+0.63%)
At close · Nov 3
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$80.78M
Shares
203.21M
Volume · Nov 3
55.12K
Avg daily vol (3M)
105.78K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Aug 12
Aug 12
Aug 12
Quarterly report
10-Q
FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2
AI summary on its way
Revenue $126.12M
▼ 0.9%
Net loss $9.81M
Diluted EPS -$0.05
Aug 10
Jul 10
Jul 9
Jun 29
Jun 25
Current report
8-K
Events of Jun 24
Charter or bylaw amendment, or fiscal year change
AI summary on its way
Jun 25
May 13
May 13
May 13
Quarterly report
10-Q
FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1
AI summary on its way
Revenue $116.93M
▼ 8.6%
Net loss $29.49M
Diluted EPS -$0.15
May 5
Current report
8-K
Events of Apr 29
Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Shareholder vote results
AI summary on its way
Mar 20
Mar 20
Mar 20
Mar 12
Mar 12
Mar 12
Annual report
10-K
FY2025, ended Dec 31
Annual report for FY2025
AI summary on its way
Revenue $500.58M
▼ 10.9%
Net loss $118.19M
Diluted EPS -$0.58
Feb 13
Feb 9
Feb 6
2025
Dec 19
Registration statement
S-3
Registration statement
Nov 10
Current report
8-K
Financial results
Nov 10
Quarterly report
10-Q
FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $124.73M
▼ 11.9%
Net loss $25.83M
Diluted EPS -$0.13
Aug 7
Current report
8-K
Financial results
Aug 7
Quarterly report
10-Q
FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $127.3M
▼ 10.1%
Net loss $24.41M
Diluted EPS -$0.12
May 28
Current report
8-K
New debt or off-balance-sheet obligation, Other events
May 12
Current report
8-K
Financial results
May 12
Quarterly report
10-Q
FY2025 Q1, ended Mar 31
Quarterly report for FY2025 Q1
Revenue $128M
▼ 10.1%
Net loss $19.26M
Diluted EPS -$0.09
May 2
Current report
8-K
Events of Apr 30
Shareholder vote results
Mar 21
Proxy statement
DEF 14A
Meeting Apr 30, 2025
Proxy statement
Mar 21
Current report
8-K
Events of Mar 19
Change of auditor
Mar 21
Annual report to holders
ARS
Annual report to holders
Mar 21
Proxy statement
DEFA14A
Proxy statement
Mar 13
Annual report
10-K
FY2024, ended Dec 31
Annual report for FY2024
Revenue $561.6M
▲ 8.3%
Net loss $84.99M
Diluted EPS -$0.40
Mar 12
Current report
8-K
Financial results
Jan 14
Current report
8-K
Events of Jan 13
Entered into a material agreement, New debt or off-balance-sheet obligation
2024
Dec 27
Current report
8-K
Other events
Dec 17
Current report
8-K
Other events
Nov 12
Current report
8-K
Financial results
Nov 12
Quarterly report
10-Q
FY2024 Q3, ended Sep 30
Quarterly report for FY2024 Q3
Revenue $141.65M
▲ 0.3%
Net loss $28.26M
Diluted EPS -$0.13
Aug 28
Current report
8-K
Events of Aug 26
Director or officer change, or executive pay, Regulation FD disclosure
Aug 7
Quarterly report
10-Q
FY2024 Q2, ended Jun 30
Quarterly report for FY2024 Q2
Revenue $141.54M
▲ 15.1%
Net loss $21.78M
Diluted EPS -$0.10
Aug 5
Current report
8-K
Financial results
Jul 22
Current report
8-K
Events of Jul 16
Entered into a material agreement, New debt or off-balance-sheet obligation, Other events
Jul 15
Current report
8-K
Other events
May 31
Current report
8-K
Director or officer change, or executive pay, Regulation FD disclosure
May 8
Quarterly report
10-Q
FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Revenue $142.41M
▲ 24.7%
Net loss $18.16M
Diluted EPS -$0.09
Showing 1–50 of 108 documents